Search is Powered by Google
Urology / Nephrology News

Post-Percutaneous Nephrolithotomy Bleeding Management. Lessons Learned In 20 Years

Main Category: Urology / Nephrology
Article Date: 02 Jul 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

ORLANDO, FL (UroToday.com) - Minimally invasive endourological surgery for renal stone diseases i.e. percutaneous nephrolithotomy (PNL) has been shown to be safe but has its potential serious complications such as massive hemorrhage which can be acute or delayed. The group from India evaluated the incidence, demography, and cause of bleeding from 5,847 patients who underwent percutaneous nephrolithotomy from 1985 and 2006.

Of note, there were 32 patients who had serious vascular complication. Pre-operative work-ups on coagulation profiles were normal. Interestingly, the time of presentation varied, with the majority presenting during the second to eighth postoperative week (63%, 20/32), 9 (28%) in the first week and 3 (9%) greater than 8 weeks. Angiography showed an arteriovenous fistula in 41%, a pseudoaneurysm in 41% and showed nothing significant in 18%. The bleeding was managed successfully in majority (81%) of patients using super selective angioemboliszation. However, 6 patients failed angioembolization, and the bleeding was managed with nephroscopy and cauterization of bleeding points (n=2) or exploration of the tract (n=4) with 2 patients ultimately requiring nephrectomy for life threatening bleeding.

The study showed the potential causes and treatment options of hemorrhagic complications of PNL. The role of super selective angioembolization in the control of bleeding was likewise highlighted. They stressed that adherence to the basic principles of PNL specifically optimal puncture through the calyx, controlled dilatation of the tract, and careful manipulation of the instruments may potentially prevent or limit these vascular complications.

Presented by Muthu Veeramoni, MD, Arvind Ganpule, MD, Sharad Bapat, MD, Mahesh Desai Nadiad, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.

Reported by UroToday.com Contributing Editor Aldrin Joseph R. Gamboa, MD

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Schizophrenia

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader


Hormonal Therapy: Prostate image Hormonal Therapy: Prostate

Prostate cancer is the second leading cancer killer of men in the U.S. Among the treatment options for this disease are surgery, radiation therapy and hormonal therapy, which limits the effects of male hormones on growing cancer cells. Find out how hormonal therapy is being used to fight prostate...

Yeast Infections Introduction image Yeast Infections Introduction

When women experience the signs of a yeast infection, they often prefer to self-medicate rather than check with their doctor. But the symptoms are similar to those of more serious conditions and only your doctor can tell the difference. Tune is as our experts share important information all women...

View more videos...